ReShape Lifesciences Inc. (RSLS)

ReShape Lifesciences Statistics

Total Valuation

RSLS has a market cap or net worth of $6.85 million. The enterprise value is $4.46 million.

Market Cap	6.85M
Enterprise Value	4.46M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

RSLS has 2.39 million shares outstanding.

Current Share Class	2.39M
Shares Outstanding	2.39M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+172.17%
Owned by Insiders (%)	0.06%
Owned by Institutions (%)	11.61%
Float	2.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.01
Forward PS	n/a
PB Ratio	0.31
P/TBV Ratio	5.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.53, with a Debt / Equity ratio of 0.11.

Current Ratio	1.53
Quick Ratio	0.79
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-157.43

Financial Efficiency

Return on equity (ROE) is -120.16% and return on invested capital (ROIC) is -128.34%.

Return on Equity (ROE)	-120.16%
Return on Assets (ROA)	-53.49%
Return on Invested Capital (ROIC)	-128.34%
Return on Capital Employed (ROCE)	-266.82%
Revenue Per Employee	$398,611
Profits Per Employee	-$192,389
Employee Count	18
Asset Turnover	0.98
Inventory Turnover	0.87

Taxes

In the past 12 months, RSLS has paid $32,000 in taxes.

Income Tax	32,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -98.99% in the last 52 weeks. The beta is 1.94, so RSLS's price volatility has been higher than the market average.

Beta (5Y)	1.94
52-Week Price Change	-98.99%
50-Day Moving Average	7.15
200-Day Moving Average	85.66
Relative Strength Index (RSI)	38.04
Average Volume (20 Days)	7,277,158

Short Selling Information

The latest short interest is 33,655, so 1.41% of the outstanding shares have been sold short.

Short Interest	33,655
Short Previous Month	43,975
Short % of Shares Out	1.41%
Short % of Float	1.41%
Short Ratio (days to cover)	0.10

Income Statement

In the last 12 months, RSLS had revenue of $7.18 million and -$3.46 million in losses. Loss per share was -$96.22.

Revenue	7.18M
Gross Profit	4.57M
Operating Income	-6.30M
Pretax Income	-10.87M
Net Income	-3.46M
EBITDA	-6.28M
EBIT	-6.30M
Loss Per Share	-$96.22

Balance Sheet

The company has $2.52 million in cash and $130,000 in debt, giving a net cash position of $2.39 million or $1.00 per share.

Cash & Cash Equivalents	2.52M
Total Debt	130,000
Net Cash	2.39M
Net Cash Per Share	$1.00
Equity (Book Value)	1.23M
Book Value Per Share	9.24
Working Capital	2.17M

Cash Flow

Operating Cash Flow	-4.47M
Capital Expenditures	n/a
Free Cash Flow	-4.47M
FCF Per Share	-$1.88

Margins

Gross margin is 63.74%, with operating and profit margins of -87.76% and -48.26%.

Gross Margin	63.74%
Operating Margin	-87.76%
Pretax Margin	-47.82%
Profit Margin	-48.26%
EBITDA Margin	-87.48%
EBIT Margin	-87.76%
FCF Margin	n/a

Dividends & Yields

RSLS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-50.57%
FCF Yield	-65.34%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 9, 2025. It was a reverse split with a ratio of 0.04:1.

Last Split Date	May 9, 2025
Split Type	Reverse
Split Ratio	0.04:1

Scores

RSLS has an Altman Z-Score of -139.73 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-139.73
Piotroski F-Score	1